Effect of organic acids on inhibition of Escherichia coli O157:H7 colonization in gnotobiotic mice associated with infant intestinal microbiota

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 93, Issue 1-2, 2008, Pages 141-149

  Momose, Yoshika ^a   Hirayama, Kazuhiro ^a   Itoh, Kikuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Escherichia coli O157:H7; Gnotobiotic mice; Infant intestinal microbiota; Motility; Organic acids

Indexed keywords

ACETIC ACID; LACTIC ACID; PROPIONIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CULTURE; CECUM; CONTROLLED STUDY; ESCHERICHIA COLI O157; FEMALE; GNOTOBIOTICS; GROWTH INHIBITION; INTESTINE FLORA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACID; ACIDS; ANIMALS; BILE ACIDS AND SALTS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; GERM-FREE LIFE; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; INTESTINES; LACTIC ACID; MICE; MICE, INBRED BALB C; PROPIONIC ACIDS;

ESCHERICHIA COLI; MUS;

EID: 37449021974     PISSN: 00036072     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10482-007-9188-9     Document Type: Article

References (32)

1. Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, Takeda Y (2004) Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7. Infect Immun 72:2240-2247
2. Benno Y, Sawada K, Mitsuoka T (1984) The intestinal microflora of infants: Composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975-986
3. Carman RJ, Simon MA, Fernández H, Miller MA, Bartholomew MJ (2004) Ciprofloxacin at low levels disrupts colonization resistance of human faecal microflora growing in chemostats. Reg Toxicol Pharmacol 40:319-326
4. Claud EC, Walker WA (2001) Hypothesis: Inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 15:1398-1403
5. Dai D, Walker WA (1999) Protective nutrients and bacterial colonization in the immature human gut. Adv Pediatr 46:353-382
6. Donskey CJ, Hume ME, Callaway TR, Das SM, Hoyen CK, Rice LB (2001) Inhibition of vancomycin-resistant enterococci by an in vitro continuous-flow competitive exclusion culture containing human stool flora. J Infect Dis 184:1624-1627
7. Edwards CA, Parrett AM, Balmer SE, Wharton BA (1994) Faecal short chain fatty acids in breast-fed and formula-fed babies. Acta Paediatr 83:459-462
8. Fenchel T (2002) Microbial behavior in a heterogeneous world. Science 296:1068-1071
9. Freter R, Brickner H, Fekete J, Vickerman MM, Carey KE (1983) Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun 39:686-703
10. Girón JA, Torres AG, Freer E, Kaper JB (2002) The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells. Mol Microiol 44:361-379
11. Guiot HFL (1982) Role of competition for substrate in bacterial antagonism in the gut. Infect Immun 38:887-892
12. Howie PW, Forsyth JS, Ogston SA, Clark A, Florey CV (1990) Protective effect of breast feeding against infection. BMJ 300:11-16
13. Itoh K, Freter R (1989) Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures. Infect Immun 57:559-565
14. Josenhans C, Suerbaum S (2002) The role of motility as a virulence factor in bacteria. Int J Med Microbiol 291:605-614
15. Momose Y, Hirayama K, Itoh K (2005) Antagonism of intestinal bacteria isolated from human infants against Escherichia coli O157:H7 infection in gnotobiotic mice. Microbial Ecol Health Dis 17:9-14
16. Mortensen FV, Møller JK, Hessov IB (1999) Effects of short-chain fatty acids on in vitro bacterial growth of Bacteroides fragilis and Escherichia coli. APMIS 107:240-244
17. Narushima S, Itoh K, Kuruma K, Uchida K (1999) Cecal bile acid compositions in gnotobiotic mice associated with human intestinal bacteria with the ability to transform bile acids in vitro. Microbial Ecol Health Dis 11:55-60
18. Ogawa K, Ben RA, Pons S, de Paolo MIL, Fernándes LB (1992) Volatile fatty acids, lactic acid, and pH in the stools of breast-fed and bottle-fed infants. J Pediatr Gastroenterol Nutr 15:248-252
19. Ogawa M, Shimizu K, Nomoto K, Tanaka R, Hamabata T, Yamasaki S, Takeda T, Takeda Y (2001) Inhibition of in vitro growth of shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int J Food Microbiol 68:135-140
20. Ohmomo S, Tanaka O, Kitamoto H (1993) Analysis of organic acids in silage by high-performance liquid chromatography. Bull Natl Grassl Inst 48:51-56
21. Ottemann KM, Miller JF (1997) Roles for motility in bacterial-host interactions. Mol Microbiol 24:1109-1117
22. Polen T, Rittmann D, Wendisch VF, Sahm H (2003) DNA microarray analyses of the long-term adaptive response of Escherichia coli to acetate and propionate. Appl Environ Microbiol 69:1759-1774
23. Postnova T, Gómez-Duarte OG, Richardson K (1996) Motility mutants of Vibrio cholerae O1 have reduced adherence in vitro to human small intestinal epithelial cells as demonstrated by ELISA. Microbiol 142:2767-2776
24. Que JU, Casey SW, Hentges DJ (1986) Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun 53:116-123
25. Savage DC (1987) Microorganisms associated with epithelial surfaces and stability of the indigenous gastrointestinal microflora. Die Nahrung 31:383-395
26. Shin R, Suzuki M, Morishita Y (2002) Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J Med Microbiol 51:201-206
27. Siegler RL (1994) Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 125:511-518
28. Silva SH, Vieira EC, Dias RS, Nicoli JR (2001) Antagonism against Vibrio cholerae by diffusible substances produced by bacterial components of the human faecal microbiota. J Med Microbiol 50:161-164
29. Snoeyenbos GH (1979) Role of native intestinal microflora in protection against pathogens. Proc Annu Meet US Anim Health Assoc 83:388-393
30. Swidsinski A, Loening-Baucke V, Theissig F, Engelhardt H, Bengmark S, Koch S, Lochs H, Dörffel Y (2007) Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 56:343-350
31. Ushijima T, Seto A (1991) Selected faecal bacteria and nutrients essential for antagonism of Salmonella typhimurium in anaerobic continuous flow cultures. J Med Microbiol 35:111-117
32. Yamamoto-Osaki T, Kamiya S, Sawamura S, Kai M, Ozawa A (1994) Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture. J Med Microbiol 40:179-187